[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
About the Journal
Editorial Board
Aims& Scopes
Journal News
Articles archive::
Current Issue
All Issues
Browse by Authors
Browse by Keywords
For Authors::
Call for Papers
Submission Instruction
Submission Form
For Reviewers::
Reviewers Section
Registration::
Registration Information
Registration Form
Contact us::
Contact Information
Contact us
Site Facilities::
Site map
Search contents
FAQ
Top 10 contents
Inform to friends
Webmail::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 33, Issue 4 (winter 2023) ::
MEDICAL SCIENCES 2023, 33(4): 435-442 Back to browse issues page
Evaluation of recorded phone calls to Iran’s Drug and Poison Information Centers: a 4 years’ study
Talat Ghane1 , Soheila Haghgoo2 , Nooshin Adib3
1- PhD of Toxicology, Food and Drug Laboratory Research Center, Food and Drug Administration, MOH&ME, Tehran, Iran , t.ghane@fda.gov.ir
2- PhD of Pharmaceutics, Food and Drug Laboratory Reference Lab, Food and Drug Administration, MOH&ME, Tehran, Iran
3- PhD of Pharmaceutics, Assistant Professor, Food and Drug Laboratory Reference Lab, Food and Drug Administration, MOH&ME, Tehran, Iran
Abstract:   (892 Views)
Background: The Drug and Poison Information Centers (DPICs) in Iran was established as a part of Iran’s Food and Drug Deputy (FDD), supervised by the Ministry of Health and Medical Education (MOH) and in other universities of medical sciences to provide services to the scientific community and public to provide quick, easy, valid and reliable access to medication information and poisoning information.
Materials and methods: This descriptive study retrospectively reviewed reported phone calls of DPICs in Iran to central division in Tehran from 2011 to 2013 and 2015. The Phone calls registered in official forms of World Health Organization (WHO).
Results: The centers received about one million calls during 4 years’ study, including 249873, 224368, 235769 and 250367 cases each year. About 64.2%±4% of callers were female. Most calls were made by the patients (54.5%±1.2%). The greater number of patients who contacted to the DPICs was in age group of 19-30 years old in all years of study. Calls mostly were focused on Adverse Drug Reactions (ADR) (15.6%±0.96%).
Conclusion: The increasing of calls showed that need to this kind of services is increased every day, more and more. The separate line for medical staff seems necessary and it seems there are need to give public more information by their physician and pharmacist or new available digital methods
Keywords: Drug and Poison Information Center (DPIC), Drug information (DI), Adverse drug information (ADR), Iran.
Full-Text [PDF 390 kb]   (622 Downloads)    
Semi-pilot: Survey/Cross Sectional/Descriptive | Subject: Pharmacology
Received: 2023/08/30 | Accepted: 2023/11/19 | Published: 2023/12/1
References
1. آall V, Gomez C, Fernandez-Llimos F. Situation of drug information centers and services in costa rica. Pharm Pract (Granada) 2006;4:1-7.
2. Mononen N, Järvinen R, Hämeen-Anttila K, Airaksinen M, Bonhomme C, Kleme J, et al. A national approach to medicines information research: A systematic review. Res Social Adm Pharm 2018;14:1106-24. [DOI:10.1016/j.sapharm.2018.01.011]
3. Rosenberg JM, Koumis T, Nathan JP, Cicero LA, McGuire H. Current status of pharmacist-operated drug information centers in the United States. Am J Health Syst Pharm 2004;61:2023-32. [DOI:10.1093/ajhp/61.19.2023]
4. Rosenberg JM, Schilit S, Nathan JP, Zerilli T, McGuire H. Update on the status of 89 drug information centers in the United States. Am J Health Syst Pharm 2009;66:1718-22. [DOI:10.2146/ajhp080563]
5. Oder M, Põld K. Estonian Experience on Establishment of a Modern National Poison Information Centre: One-year Profile of Phone Calls in 2012. Asia Pac J Med Toxicol 2013;2:42-7.
6. Almazrou DA, Ali S, Alzhrani JA. Assessment of Queries Received by the Drug Information Center at King Saud Medical City. J Pharm Bioallied Sci 2017;9:246-50. [DOI:10.4103/JPBS.JPBS_166_17]
7. Churi S, Abraham L, Ramesh M, Narahari MG. Evaluation of poison information services provided by a new poison information center. Indian J Pharmacol 2013;45:496-501. [DOI:10.4103/0253-7613.117781]
8. Ponampalam R, Loh CS. Cost Benefits of the Drug and Poison Information Centre in Preventing Unnecessary Hospitalisation: The Singapore Experience. Hong Kong J Emerg Med 2010;17:45. [DOI:10.1177/102490791001700108]
9. Ghane T, Behmanesh Y, Khazei F. Annual Report of Drug and Poison Information in Iran from March 2012 to March 2013. Acta Med Iran 2016;54:525-9.
10. Nikfar S, Abdollahi M, Cheraghali A. Going from strength to strength; a drug and poison information centre. Essent Drugs Monit 2000;28:30-1.
11. Ghane T, Saberi S, Davoodabadi M. Descriptive Analysis of Recorded Phone Calls to Iran Drug and Poison Information Centers during 2011-2012. Asia Pac J Med Toxicol 2013;2:48-51.
12. Iman K, Afsaneh V, Najme T, Nazafarin H-M, Motahare M-B. Performance of Drug and Poison Information Center within a Referral University Hospital in Southwest of Iran. J Pharm Care 2018;5:22-26.
13. Vassilev ZP, Chu AF, Ruck B, Adams EH, Marcus SM. Evaluation of adverse drug reactions reported to a poison control center between 2000 and 2007. Am J Health Syst Pharm 2009;66:481-7. [DOI:10.2146/ajhp080267]
14. Rao PGM, Jimmy B. Assessment and evaluation of drug information services provided in a South Indian teaching hospital. Indian J Pharmacol 2005;37:315. [DOI:10.4103/0253-7613.16856]
15. Shadnia S, Soltaninejad K, Sohrabi F, Rezvani M, Barari B, Abdollahi M. The performance of loghman-hakim drug and poison information center from 2006 to 2008. Iran J Pharm Res 2011;10:647-52.
16. Maruzi A, Sabbaghian-Tousi S, Karimi G, Jabbari R, Elyasi S. A Ten-year Report of Drug and Poison Information Center in Mashhad, Iran 2007-2017. Iran J Pharm Res 2021;20:e124358.
17. Entezari-Maleki T, Taraz M, Javadi MR, Hajimiri MH, Eslami K, Karimzadeh I, et al. A two-year utilization of the pharmacist-operated drug information center in Iran. J Res Pharm Pract 2014;3:117-22. [DOI:10.4103/2279-042X.145368]
18. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-5. [DOI:10.1001/jama.279.15.1200]
19. Riedl MA, Casillas AM. Adverse drug reactions: types and treatment options. Am Fam Physician 2003;68:1781-90.
20. Aung AK, Zubrinich CM, Goh MSY, Snyder B, Tang MJ, Khu CYL, et al. Development and application of adverse drug reactions reports QUality Algorithm (AQUA-12) score: a single-centre quality improvement initiative. Eur J Clin Pharmacol 2023;79:513-22. [DOI:10.1007/s00228-023-03457-9]
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA

XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ghane T, Haghgoo S, Adib N. Evaluation of recorded phone calls to Iran’s Drug and Poison Information Centers: a 4 years’ study. MEDICAL SCIENCES 2023; 33 (4) :435-442
URL: http://tmuj.iautmu.ac.ir/article-1-2165-en.html
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 33, Issue 4 (winter 2023) Back to browse issues page
فصلنامه علوم پزشکی دانشگاه آزاد اسلامی واحد پزشکی تهران Medical Science Journal of Islamic Azad Univesity - Tehran Medical Branch
Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4710